There will be uprampers (galore) and downrampers (4 legged animals) in any public stock forum so nothing new there. FYI I used to be a holder till the AGM in 2017 when to me the risk profile of the business changed. Nulac was a good strategic acquisition but recent announcements have been a little cute i.e. lumping Nulac revenue with IF sales and lack of clarity around why seemingly the first preferred CNCA partner fell through yet no announcement to the market. Transparency is key with a large retail shareholder base with low analyst coverage but it seems they are taking advantage of this. Analysts (as Morgans have said) would ridicule any company that seeks to obscure key performance metrics uch as organic growth of their main product line.
Add to My Watchlist
What is My Watchlist?
